Jonathan Penny

Jonathan Penny

Chief Commercial Officer, Medical & Clinical Markets

Jonathan Penny is NuroKor’s Chief Commercial Officer for Medical and Clinical Markets. With 16 years’ experience in senior medical sales across UK, EMEA and Australian markets, the former International Head of Sales has headed teams across specialties including orthopaedics, cardiac, vascular and anaesthetics.

Jonathan specialises in increasing market penetration of medical products and brings a solid track record of building direct sales teams, establishing new markets and managing distributor networks. His final position at leading medical device company Nevro Medical saw him helping to grow the company to a listed PLC with $390million revenue. As part of this, he was responsible for establishing and developing direct and distributor models across 16 different countries.


Jonathan  started his career at medical and surgical product supplier Vygon (UK), before joining Atrium Medical Europe and global and NHS healthcare supplier Baxter Healthcare (formerly Apatech).

He said: “I have spent over 10 years working within the pain field and seen first-hand the effect it has on patients. To join a company that can offer a solution, that can be applied in many different patient groups and is both easy and effective, was an opportunity I wanted to be a part of. I see NuroKor changing the way patients receive the correct type of treatment – with it being tailored to their needs. And it enables clinicians to have the right tools to do this easily and effectively.

“The team Rick has brought together shows the ambition of NuroKor. The strength of the therapy can be seen in the wide-ranging group of ambassadors and customers using the products, these are two of the most important factors in building a successful company.”
Jonathan Penny

Jonathan Penny

Chief Commercial Officer, Medical & Clinical Markets

Jonathan  started his career at medical and surgical product supplier Vygon (UK), before joining Atrium Medical Europe and global and NHS healthcare supplier Baxter Healthcare (formerly Apatech).

He said: “I have spent over 10 years working within the pain field and seen first-hand the effect it has on patients. To join a company that can offer a solution, that can be applied in many different patient groups and is both easy and effective, was an opportunity I wanted to be a part of. I see NuroKor changing the way patients receive the correct type of treatment – with it being tailored to their needs. And it enables clinicians to have the right tools to do this easily and effectively.

“The team Rick has brought together shows the ambition of NuroKor. The strength of the therapy can be seen in the wide-ranging group of ambassadors and customers using the products, these are two of the most important factors in building a successful company.”
Jonathan Penny

Jonathan Penny

Chief Commercial Officer, Medical & Clinical Markets

Jonathan Penny is NuroKor’s Chief Commercial Officer for Medical and Clinical Markets. With 16 years’ experience in senior medical sales across UK, EMEA and Australian markets, the former International Head of Sales has headed teams across specialties including orthopaedics, cardiac, vascular and anaesthetics.

Jonathan specialises in increasing market penetration of medical products and brings a solid track record of building direct sales teams, establishing new markets and managing distributor networks. His final position at leading medical device company Nevro Medical saw him helping to grow the company to a listed PLC with $390million revenue. As part of this, he was responsible for establishing and developing direct and distributor models across 16 different countries.


Jonathan  started his career at medical and surgical product supplier Vygon (UK), before joining Atrium Medical Europe and global and NHS healthcare supplier Baxter Healthcare (formerly Apatech).

He said: “I have spent over 10 years working within the pain field and seen first-hand the effect it has on patients. To join a company that can offer a solution, that can be applied in many different patient groups and is both easy and effective, was an opportunity I wanted to be a part of. I see NuroKor changing the way patients receive the correct type of treatment – with it being tailored to their needs. And it enables clinicians to have the right tools to do this easily and effectively.

“The team Rick has brought together shows the ambition of NuroKor. The strength of the therapy can be seen in the wide-ranging group of ambassadors and customers using the products, these are two of the most important factors in building a successful company.”
Meet the rest of our team
Rick Rowan
Chloe Stockwell Clark
Maddy Kennedy
Mr Raj Bhattacharya
Dr Irem Tezer Ates
Dr Ashish Shetty
Jo Rogers
Aelin Raines
Mark Hopkins
William Ripley
Tanja Novakovic
Jonathan Corns
Shaina Kumar
Matt Williams
Ben Simons
Sara Fitzharris
Lisa Wynne
Somi Arian
Trevor Bolland
Justine Southall
Ieuan Evans

The means to a better quality of life is within reach, all through the power of bioelectronic technology.